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Abstract
The present chapter highlights the most important information about microcirculation
and its evaluation using contrast-enhanced ultrasonography (CEUS). In the beginning
it  outlines  some  general  considerations  about  microcirculation,  together  with  its
morphological  and  physiological  particularities  under  normal  and  pathological
circumstances. The ultrasonographic (US) evaluation of vascularity is based on the
Doppler technique and the harmonic technique using contrast agents. Then it presents
briefly the Doppler ultrasound (DUS) and discusses its most important current and
emerging indications. CEUS is presented extensively, covering the fundamentals of
sonographic contrast agents, harmonic imaging and quantification techniques. A special
focus is placed not only on the current and emerging indications of CEUS but also on
the advantages and limitations of the method. This chapter also incorporates informa-
tion  about  experimental  CEUS  applications  and  future  perspectives.  CEUS  is  the
recommended US method for the characterization of microcirculation. The results of
the examination are displayed in real-time, under the eyes of the examiner, while the
quantitative assessment of the contrast agent kinetics parameters is easy to perform.
This method allows a precise definition of the healthy or pathologic state of an organ
and the follow-up of treatment response.
Keywords: microcirculation, contrast agent, ultrasonography, Doppler ultrasonogra-
phy, microvascular kinetics
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1. Introduction
1.1. Microcirculation: general considerations: morphological and physiological
particularities under normal circumstances
Microcirculation (MC) represents the segment of the circulatory system that includes vascular
structures with a diameter <150 μm; it is present in all tissues and organs (except for cornea
and intervertebral disks). This dimensional threshold corresponds to small arteries, arterioles,
capillaries and venules. The consensus on this definition is still under debate, therefore in the
case of the small arteries (anatomically defined as small, but with a caliber >150 μm) it is unclear
whether they should be regarded as part of the MC [1]. The capillaries are organized as a
circulatory network (bed)  which provides an enormous access area for  the blood to the
parenchyma (Figure 1). There is an ordered distribution pattern of the capillaries, which is
also organ-specific. The ordered spatial distribution of the capillaries, correlated with the
degree of specialization of the structured cells into the parenchyma, represents the premise
for the complex functions specific to each organ: liver, spleen, kidney, thyroid, etc. The main
function of MC is to allow and modulate the transfer of nutrients and oxygen to the tissues
according to their needs.  An adequate operation of this process is a prerequisite for the
structural and functional integrity of various tissues and organs. Another function of MC is
to prevent the variations of hydrostatic pressure at the level of the capillaries, variations which
interfere with normal tissue exchanges. Under normal circumstances, there are significant
variations of the vessel caliber and blood volume. These are determined by a number of
physiological parameters, such as temperature, arterial pressure, physical and mental activity,
age. Other factors that influence MC are feeding, stress, medication, smoking and finally
pathological changes. MC alterations include various pathological processes since they may
represent both the determining factors and their consequences.
Figure 1. Microcirculation outline. A – arteriole; V – venule; C – capillaries.
1.2. Morphological and physiological particularities under pathological circumstances
Microcirculation, as described above, is an important element of the ensemble that makes up
the different tissues and organs. Pathological states have a significant influence on MC.
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Inflammation represents the first line of defense against traumatic, pathogenic or toxic injuries
and is based on a complex local process that involves microvascular structures, cellular and
immunological events. The consequences of these local changes may have an impact at a
systemic level. During acute inflammation the alterations of the vascular caliber and blood
flow occur immediately after the injury. The transient vasoconstriction of the arterioles
represents the initial change and is followed by vasodilation and thus increased blood flow.
Increased vascular permeability causes afterwards the slowing of the blood flow, stasis and
interstitial edema. The extension of the inflammatory process in time (weeks, months) is
characteristic for chronic inflammation. Within this process the active inflammatory altera-
tions, tissue damage and tissue repair happen simultaneously (Figure 2).
Figure 2. Inflammation of the skin. Dilation (arrowhead) and increased permeability of the vessels are shown (arrows).
Angiogenesis (formation of new vessels) is a central phenomenon in chronic inflammation and
represents the development of new vessels from the pre-existing vascular structures. The event
is complex and involves various types of cells, growth factors, cytokines, adhesion molecules
and signal transformation processes [2]. These factors thus contribute to blood vessels
development, maintenance and remodeling.
In physiological processes such as wound healing or during menstrual cycle, angiogenesis is
temporarily activated. On the other hand, it also plays an important role in the onset, devel-
opment and spread of malignancies [3, 4]. Tumors under 1–2 mm receive oxygen and nutrients
by diffusion, but their further growth requires the development of new feeding vessels.
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Without angiogenesis tumors cannot grow beyond this size and cannot metastasize. The
development of benign tumor masses also requires a transient activation of angiogenesis. In
their case the resulting vessels have a relatively linear pattern and ordered ramifications.
Conversely, the progression of malignant tumors involves a permanent activation of angio-
genesis in order to sustain tumor growth. As a result, new vessels are quickly multiplying and
developing chaotically, forming a wide, tree-like spatial structure. This structure penetrates
into the tumor and ensures a large diffusion area, in contact with the neoplastic cells. Even
though the tumor vasculature originates from the normal vessels of the host tissue, the
architecture is significantly different. Tumors present an anarchic, inhomogeneous, vascular
network, often with dilated, saccular, tortuous structures and irregular ramifications
(Figure 3). Tumor cells may be found in the endothelium and the blood flow is chaotic,
bidirectional and unsteady [5–7]. From a functional point of view, the vessels present an
abnormal permeability for large macromolecules, while tissue oxygenation and metabolic
residue removal are inefficient. The perfusion rate in many of these tumors is slower than in
normal tissues and the average flow rate of erythrocytes may be one level of magnitude lower
than in physiologic conditions [8]. Unlike in normal vessels, in neoplastic vessels the charac-
teristic relationship between vessel size and the erythrocyte flow rate is missing. Blood flow
through the tumor bed is restrained by the increased downstream resistance and focal leakage.
The heterogeneous features of tumor vascularity generate obstacles for the penetration of
therapeutic agents and contribute to the development of the abnormal tumor environment. In
this way the efficiency of various therapies is reduced while the most aggressive and potentially
metastatic cancerous cells are being selected [8].
The main promoter of angiogenesis is the vascular endothelial growth factor (VEGF). In normal
circumstances it is suppressed by the Von Hippel-Lindau (VHL) protein, while in the case of
tumors it is overexpressed [9]. With the use of immunohistochemistry methods, the CD34
endothelial antigen is marked with specific antibodies and a parameter called microvascular
density (MVD) is calculated by means of automatic measurement methods. This is an indicator
of the degree of angiogenesis, and some studies indicate a correlation between MVD and cancer
patients’ survival [10]. The emerging use of MVD is represented by the evaluation of the
tumor’s response to systemic treatment. Studies performed to this date revealed the utility of
MVD for the measurement of the effect of tumor angiogenesis disrupting therapies [11]. These
therapies, called antiangiogenic therapies, are designed to reverse vascular and tumoral
environment abnormalities and to determine the “normalization” of the tumor vessels’
function [12]. As a consequence, there is an improvement in the cytotoxic agents’ penetration
and the radiation therapy outcome.
Ischemia represents the partial reduction (chronic ischemia) or complete suppression (acute
ischemia) of the arterial flow in an organ or anatomical region. The causes are manifold:
circulatory alterations such as embolism and thrombosis; degenerative and inflammatory
arterial conditions—atherosclerosis and arteriosclerosis; arterial spasm; arterial hypotension.
In acute ischemia there is a sudden and complete suppression of the circulation and the
evolution toward infarction is variable, depending on the existence of collateral circulation.
Chronic ischemia begins with the reduction of the capillaries caliber and blood flow in a more
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or less well-defined area, depending on the feeding arterial network which may or may not be
terminal. There are also associated phenomena to collateral feeding vessels formation. Within
the necrotic, infarction area, there is no circulatory bed, only a more or less liquefied tissue,
completely or partially replaced by fibrotic structures.
Figure 3. Angiogenesis outline. A small tumor (T) receives nutrients and oxygen by diffusion (a). As the tumor grows
normal adjacent vessels (V) multiply quickly and penetrate into the tumor (b, c).
2. Current ultrasonographic techniques used for the evaluation of
microcirculation: Doppler ultrasonography
2.1. General principles
This technique detects blood flow down to velocities of 2 cm/s, allows the color coding of the
flow (“color flow map” technique – CFM; “power Doppler“- PD), velocity and flow measure-
ments (spectral Doppler). Only vascular structures with a diameter over 100 μm can be
analyzed [13, 14]. The physical principle that governs this method is the Doppler effect. For all
types of waves (including sound waves) it entails the change of the received signal frequency,
when the source of the wave and/or the receiver is moving toward or away from one another
Figure 4. Doppler effect outline. E – emitted sound wave fascicle; R – reflected fascicle; D – direction of movement of
blood cells; A – angle between sound wave fascicle and blood cells direction of movement.
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(Figure 4). The receiver’s movement toward a stationary source leads to the detection of higher
frequencies. If the receiver moves away from the source it encounters less cycles per second
and it will register a wave with a lower frequency than that emitted by the source. In ultraso-
nographic (US) equipment both the source and the receiver are positioned close to one another
inside the transducer. The emitted sound wave fascicle is reflected from the interfaces existing
between/in various tissues and afterwards these waves are received and represent the basis
for the formation of the US image (Figure 5). The movement of the blood cells toward the
transducer determines an increase of the reflected wave’s frequency, while the opposite
movement determines a frequency decrease.
Figure 5. Examples of spectral and color Doppler. On the left: the left testicle (black asterisk) is investigated by spectral
Doppler. The measurement sample (arrowhead) is placed inside an artery. The bottom portion of the image displays
the spectral Doppler waveform (Wf), in which blood flow velocity (in cm/s) within the Doppler sample is plotted ver-
sus time. On the right: a superficial tumoral mass (white asterisk) is investigated with CFM. Flow toward the transduc-
er is represented with shades of red and yellow, whereas flow in the opposite direction is indicated with shades of blue
(arrows).
The difference between the received and the emitted sound wave, called differential frequency,
is dependent on the emission frequency, propagation velocity of the waves into the tissues, the
velocity of the detector and the angle between the detector's direction of movement and the
sound wave fascicle. Placing a “measurement sample” inside a vessel will include groups of
cells moving at different velocities, each group determining a signal with a particular
differential frequency. Therefore, a complex US signal is generated from inside the blood
column, which can be analyzed using a specter of frequencies with the help of Fourier
techniques. The frequencies which compose the specter are then transformed into velocities
using the Doppler equation.
2.2. The applicability of Doppler ultrasonography for the evaluation of normal and
pathological circumstances
Within the limits of the spatial and temporal resolution offered by the latest equipment, DUS
allows the characterization of the circulatory bed. The normal circulatory bed consists of fine
vessels with a radial orientation, from the organ's hilum toward the capsule. This pattern is
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more obvious in the case of large organs such as the liver or the spleen. Other organs such as
the kidney, the thyroid and the testicle have a different appearance, also characteristic, of the
normal vascularity, easy to identify and describe.
The features of the circulatory bed during inflammation have been investigated in various
studies aimed to detect and measure vascular changes. Rheumatology is one of the beneficiary
fields of these US techniques. The common indications include the evaluation of the inflam-
mation, the appreciation of the therapeutic response and the differentiation between inflam-
matory and degenerative pathology. DUS may identify the augmentation of the blood flow in
the inflammation of the synovial and periarticular structures, tendon insertion and sheath. The
increase of the blood flow is associated with the histologic identification of the intra-articular
pannus [15]. For the time being the detection of the Doppler signal represents an integrated
part of the definitions of musculoskeletal conditions (Figure 6). Thus, synovitis is defined as
an abnormal, hypoechoic, intra-articular structure that is only slightly compressible and which
may present Doppler signal. A fluid collection is defined as an hypoechoic or anechoic intra-
articular structure which can be dislodged and does not present Doppler signal. Detection of
the Doppler signal is also included in the definitions of tenosynovitis and enthesopathy [15,
16]. The method provides high accuracy in showing active synovitis and accompanied by
contrast agent (CA) administration it correlates very well with other imaging methods such
as contrast-enhanced magnetic resonance imaging (CE-MRI) [17].
Figure 6. Example of hip synovitis in a child. Synovial thickening is indicated by the asterisk. Power Doppler identifies
augmentation of blood flow in the inflamed synovia (arrow).
Another established application of DUS is in the male genital pathology. An increased vascular
signal observed upon the CFM or PD examination of an enlarged, hypoechoic epididymis
reveals the hyperemia characteristic of acute epididymitis. A similar appearance is identified
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in the case of acute orchitis. Spectral Doppler shows a high velocity flow and low resistance in
these situations (Figure 7).
Figure 7. Different alterations of the vasculature identified by CFM. The left image presents a patient with orchitis
(acute inflammation). The testicle (asterisk) is examined with CFM and an increased vascular signal is observed (ar-
rows). The right image portrays the evaluation of angiogenesis in a malignant tumor (HCC). The tumor (asterisk) is
depicted in a superficial liver (L) segment and CFM identifies the tumor vasculature (arrows).
In tumors, DUS may identify specific circulatory patterns both in benign (e.g., focal nodular
hyperplasia [FNH]) and malignant lesions (for instance, the “basket” circulatory pattern is
specific to hepatocellular carcinoma (HCC)) (Figure 7). The detection of malignancy through
DUS depends on the presence of an increased, asymmetric blood flow in a certain region, due
to the higher number and size of the vessels. Studies performed on different types of tumors
(e.g., skin melanomas) proved that DUS accurately identifies the process of neoangiogenesis
and may constitute a prognosis criterion for the recurrence potential of aggressive tumors [18,
19].
As regards the ischemic tissues, the lack of Doppler signal reflects the deficit or absence of
blood flow within the vessels of the affected area. This finding must be correlated with the
clinical status of the patient and with other investigations, because, for example, in the case of
renal infarction, the differentiation from a parenchymal pathology that evolves with hypo-
perfusion is difficult. This particular situation owes to the DUS limitations in identifying the
slow flow at the level of the capillaries when low-frequency US equipment is used (3–5 MHz).
Furthermore, the ischemic process is often associated and compensated with the development
of a secondary circulatory network which presents reversed flows. Power Doppler mode may
overcome this limitation, but it is excessively sensitive and nondiscriminative toward other
types of movement such as tissue vibrations and surrounding organs’ motility.
Nevertheless, there are situations when DUS may provide indirect information regarding the
capillary perfusion status. In a recent study a positive correlation has been established between
skin perfusion pressure at the level of the feet and Doppler flow measurements within tibial
arteries [20]. This finding has important implications both in the therapeutic approach of leg
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ulcers and in the evaluation of skin grafts’ viability [20]. The situation is identical in the case
of organ transplantation.
The quantification of renal vascularity through spectral Doppler is another area that is of
interest and up-to-date. There are numerous studies that have succeeded to correlate the
alterations of the Doppler parameters with various conditions. The resistivity index (RI,
calculated as [peak systolic velocity – end diastolic velocity]/peak systolic velocity) represents
the most frequently used parameter to describe the alterations of renal vascularity in relation-
ship with renal impairment. In adults the normal value at the level of the interlobar/arcuate
arteries is between 0.6 and 0.7. Renal vasoconstriction encountered in cases of complete
pyelocaliceal obstruction is reflected in the elevation of the RI above the normal limits.
Although nonspecific, RI > 0.8–0.9 has been demonstrated to be the strongest predictor for
renal graft dysfunctionality [21].
Another Doppler application, namely the laser Doppler imaging technique, is still subject to
continuous improvement. It is also based on the Doppler principle and uses a light fascicle
emitted by a laser source which is reflected by circulating erythrocytes and static tissue
structures. There are major advantages to this method in assessing the pathology of superficial
structures, such as the skin, since it can measure at 95–100% accuracy the depth of a burn – a
value that has not been reached by other methods, thus having implications in the therapeutic
conduct [22].
2.3. Limitations and advantages of Doppler ultrasound
Limitations of the Doppler technique consist mainly of the following:
a. the variability from one examination to another, as well as inter- and intraobserver
variability;
b. the difficulty in obtaining the Doppler signal from a single target vessel in certain
conditions such as a tumor with numerous feeding pedicles and a sinuous spatial
trajectory;
c. the dependence of spectral ultrasonography on the insonation angle (it has to be less than
60° in relation to the axis of the vessel);
d. the need to standardize the exploration by using more parameters that must be identical
during each examination (wall filter, color gain, scan frequency) in order to ensure the
reproducibility of the method [23].
There are ways to quantify the Doppler signal which contribute to the improvement of
reproducibility. The main measurable parameters in the case of the spectral method are blood
velocity, its relative volume and flow rate. The data obtained by the color-coded technique may
be postprocessed by quantifying the number of color pixels within a target area. In situations
where an adequate examination protocol is available this information allows the evaluation of
tumor response to chemotherapy. The percentage of colored pixels from the total number of
pixels present in the target area (called “vascularity index”) represents an approach similar to
the digital evaluation of MVD used in immunohistochemistry [24]. The new 3D color-coded
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Doppler techniques allow the creation of spatial models that illustrate tumoral circulation
characteristics [25].
The most important advantages of the Doppler method are:
a. it is noninvasive;
b. it is available on a large scale since most ultrasound machines are equipped with Doppler
functions;
c. it offers the possibility to study broad anatomical areas.
3. New ultrasonographic techniques in the evaluation of clinical
microcirculation. Intravenous contrast harmonic ultrasound
3.1. Contrast agents used in ultrasonography
Ultrasonographic contrast agents (CAs) are basically echoenhancers that are administered to
patients to improve the diagnostic yield.
Joyner mentioned the ultrasonographic contrast effect for the first time in 1960, and during the
initial experiments used standard saline solution as a contrast agent for the identification of
mitral valve echoes [26]. The saline solution is still used today to evaluate cardiac shunts.
Currently the contrast agents consisting of gas microbubbles encapsulated in a lipid, protein
or polymer shell are the most widespread and used. These remain strictly intravascular and
the encapsulation ensures a longer life of the microbubbles, up to several minutes, unlike the
unencapsulated ones which are rapidly dissolved into the blood pool. To ensure the slow
diffusion into the blood, gases such as perfluorocarbon, sulfur hexafluoride or nitrogen are
found in most of these agents. The size of the microbubbles ranges between 1 and 5 μm and
is comparable with that of erythrocytes. The CA is administered intravenously (i.v.), in a bolus
dose of 2.4 ml (SonoVue, Bracco, Italy) or by continuous infusion. The newer, more sensitive
equipment allows an efficient examination even with lower doses (e.g., 1 ml). For the injection,
a special kit is used in which the CA is prepared by mixing with a saline solution and strongly
shaking the recipient. The elimination of the CA components is made through the lungs and
by hepatic metabolization.
3.2. Harmonics based ultrasound imaging
The high-pressure fluctuations of the sound wave determine a disproportionate change of the
microbubbles’ radius, thus triggering a nonlinear response. In this situation, the ultrasound
waves reflected by the microbubbles are characterized by different frequencies compared to
the incident wave, both higher and lower. These are called harmonics, and the second harmonic
represents the foundation of “second harmonic imaging” techniques. These detect and convert
into image only the second harmonic signal from the scattered ultrasound. To obtain a better
contrast-to-tissue ratio, a low mechanical index (MI) is used (Figure 8). The MI is always
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displayed on the ultrasound machine since it is a critical parameter in contrast-enhanced
ultrasonography (CEUS). It represents the amount of negative acoustic pressure within an
ultrasonic field. The examiner can modify the MI which in turn will prompt different micro-
bubble responses and modulate the output signature of CAs.
Figure 8. Spectacle view of the testes (asterisks) after administration of CA. Harmonic imaging with low mechanical
index (MI = 0.1) sharply identifies testicular microcirculation (arrows).
3.2.1. Techniques with a variable mechanical index
These incorporate two different approaches, based on low and high MI. The low MI technique
(MI < 0.2) reduces the microbubble destruction and thus the evaluation of the perfusion can
be performed over a relatively long period of time. The high MI (MI > 0.4) approach enables a
more accurate characterization of the CA kinetics but could generate adverse biological
responses.
Techniques with a low MI include pulse inversion imaging; amplitude/power modulation;
power-modulated pulse inversion. The pulse inversion implies the emission down the same
transmit line of two consecutive pulses, the second one being identical but 180° inverted with
respect to the first pulse. Given the nonlinear response of the CA, the reflected ultrasound
waves will be nonidentical and their sum will cause the cancellation of the fundamental part
of the signal, the image being formed from the remaining signal. Although the technique has
the advantage of sparing the microbubbles, it has the disadvantage of a decreased frame rate
which is synonymous to a decreased temporal resolution.
The amplitude/power modulation technique requires the transmission of 2–3 pulses with
identical phase and different magnitude. The signals received are combined in such a way that
the sum of the pulses with low amplitude is subtracted from the high-amplitude pulse. Since
pulses with low amplitude are weak harmonic generators, the difference between the received
pulses is due to the nonlinear response of the CA. The technique of power-modulated pulse
inversion is a combination of the two techniques described above. The pair of pulses trans-
mitted in the same direction differs both in amplitude and phase, thereby providing a better
detection of the nonlinear signals.
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High MI-based techniques cause a rapid destruction of most of the microbubbles inside the
examination window. The low and high MI techniques are commonly combined (“destruction-
replenishment” technique); the examination starts with low MI and after the homogenization
of the CA perfusion, the high MI mode is activated.
3.3. The safety of contrast microbubbles
Ultrasonographic contrast agents present a high safety profile and a low incidence of side
effects. Compared to other imaging techniques (CT, MRI) they do not lead to renal toxicity and
do not alter the thyroid function. The incidence of anaphylactic reactions is very low (<0.002%)
[27]. The most important circumstances in which CA administration is forbidden are breast-
feeding; recent acute coronary syndrome; right-to-left shunts and unstable ischemic heart
disease. The in vitro studies have identified a number of possible biological effects resulting
from the interaction of the ultrasound wave with microbubbles and cells; as such sonoporation
(the appearance of small cracks in the cell membrane), hemolysis and cell death may be
encountered. Studies in animal models have shown that the use of high MI (≈0.4) may cause
glomerular hemorrhage, but in the current clinical practice MI is set around a value of 0.1 [28].
Mortality associated with CA administration is low (1: 500,000) and studies that included large
groups of patients concluded that there is no higher risk of death for patients who underwent
CA administration compared to controls [29, 30].
4. The evaluation of microcirculation using i.v. contrast-enhanced harmonic
ultrasound: experimental and animal models: clinical applications
4.1. General considerations
CEUS allows the assessment of microcirculation down to the level of very small diameter
vessels – such as 40 μm [31]. Although in the capillary bed the blood flow velocity is very low
and sometimes interrupted, CEUS allows the visualization of the CA even in these situations.
Before CA administration, the system is set as follows: MI between 0.09 and 0.11; the ‘Time
Gain Compensation’ buttons aligned in the middle position; the overall gain is reduced to the
value at which tissue echoes begin to disappear; a single focus set under the region of interest
(ROI) is used. The intravenous administration (e.g., through the cubital vein) of the extempo-
raneously prepared CA is followed by the administration of 10 mL of saline solution bolus.
The assessment of the ultrasound images is continuous, beginning from the time of injection
until the appearance of the first echoes – called “arterial phase” (10–20 s later), and afterwards
until the echoes disappear completely (called "late" venous, tissue or combined phase). The
use of the dual image, B mode and contrast mode, is recommended since it helps maintain the
area of interest within the insonation plane. To correctly assess the lesions, the examination
must be centered on a single structure which will be continuously evaluated for several
minutes. To obtain additional information on synchronous lesions, a new CA injection must
be administered (CA does not present toxic/lethal doses).
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4.2. The analysis of the CA progression
It consists of continuous and real time observation, of the CA transition pattern through the
ROI for at least 60–90 s, allowing the characterization of the CA kinetics, from the moment it
enters into the circulatory bed (wash-in) and ending with its complete exit (wash-out). The
separation between the two is given by the moment when the signal reaches maximum
intensity. The digital recording of the examination as video clips facilitates the CA kinetics
analysis through ROI, which can be quantified based on qualitative and quantitative param-
eters. Thus, the CA transition through the region of interest is divided into different temporal
phases. The first is the arterial phase (from 10–20 to 30–45 s), which is marked by an abrupt
increase of the signal intensity caused by the appearance of the microbubbles. The examination
continues with the venous phase, which begins 30–45 s after the injection, and during which
the signal intensity reaches a plateau and then gradually drops until it completely disappears.
With the exception of the liver and lungs, most organs have a single blood supply (arterial).
In the case of the liver the blood supply is ensured through the hepatic artery and the portal
vein. This means that after the arterial phase there is an additional vascular intake phase – the
portal venous phase (60–120 s) [32]. The liver and spleen display a particular behavior because
they have the tendency to retain more microbubbles than other organs. This is due to the
accumulation of CA at the level of the sinusoids (in the case of the liver) as well as its capture
by the reticulohistiocytic system (in the case of liver and spleen). Consequently, the CA washing
phase ('wash-out') is longer compared to other organs, and is called the late phase (up to 4–
6 min).
4.2.1. The semiqualitative analysis of the CA progression
Throughout a particular region it is performed by evaluating the following [33]:
a. the moment of arterial phase occurrence (depends on the cardiac activity as well as on the
distance between the vein wherein CA is administered and the organ subject to exami-
nation);
b. the celerity and length of the arterial phase (conditioned by the capillary bed compliance);
c. the direction of the CA penetration from the organ’s hilum toward the capsule;
d. the penetration and spatial distribution characteristics of the CA in the ROI (in relation
with the size and number of the feeding vessels and their spatial distribution);
e. the enhancement pattern (homogeneous or nonhomogeneous in relation to the permea-
bility of the capillary bed);
f. the time and speed of the contrast wash-out (in relationship with the arteriovenous shunts
that may indicate the malignant nature of the region of interest);
g. the wash-out direction;
h. the wash-out pattern.
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4.2.2. The quantitative analysis of the CA progression
It is based on the graphic representation of the variation in time of the CA signal intensity
within the blood column (Figure 9). This can be done using the ultrasound system or third-
party software (e.g., ImageArena, TomTec). The representation is achieved by applying an
equation adapted to the blood flow, which results in a time-intensity curve (TIC). The TIC is
traced with utmost accuracy when the ROI is stationary. Because in daily practice, with the
exception of superficial organ lesions (e.g., lymph nodes), most lesions are mobile during the
examination due to the respiratory movements, postprocessing applications were designed to
compensate these movements [34]. The TIC analysis is suitable both for techniques with a low
MI (CA administered in bolus) and high MI (CA administered in a continuous infusion coupled
with the “destruction-replenishment” technique), as it allows the examiner to set the time when
the various parameters of the curve are calculated. The microbubble destruction technique, in
the context of continuous infusion, leads to a more accurate characterization of the CA kinetics
and allows repeated measurements for the same ROI as well as for other regions. The relative
limitations of this technique are the lengthy examination time, the possible biological effects
of high MI and the need to use special perfusion pumps [35]. The detailed analysis of the TIC
curve is performed automatically by the software and is programmed to calculate mathemat-
ical parameters derived from the perfusion equation which are then integrated into the context
by the examiner. They provide useful information for determining [36]:
Figure 9. CEUS of a renal tumor. The tumor is depicted in the renal cortex and entirely outlined in green; a smaller
region of the tumor parenchyma is outlined in purple; the normal renal cortex is outlined in yellow. In the lower part
of the image the TICs were plotted for each of the abovementioned ROIs based on the timing and intensity of the ech-
oes.
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a. the circulatory bed volume – the maximum intensity of the signal referred to as "peak
intensity" (PI) and respectively the “area under the curve” (AUC);
b. the flow rate – the time elapsed from moment '0' until the point of maximum intensity –
"time to peak" (TTP);
c. the enhancement phase of the circulatory bed – "wash in time" (WIT – the time elapsed
from the time of 5% enhancement until 95% enhancement);
d. the wash-out phase of the circulatory bed – "wash out time" (WOT – representing the time
from the systolic ascension until the full exit of CA from ROI);
e. the rise time –“rise time” (RT);
f. the average transit time through the region of interest – “'mean transit time” (MTT).
4.3. Advantages and limitations of CEUS
Specific CEUS advantages consist of the following:
a. lack of ionizing radiation;
b. repeatability;
c. the possibility to perform a bed-side examination;
d. relatively low costs (as compared to other sectional imaging techniques);
e. time needed for examination is short;
f. the possibility to perform it on patients at risk or with contraindications to iodine agents
or gadolinium administration;
g. higher spatial and temporal resolution than CT or MRI;
h. the ability to detect vessels even at very low velocities has been shown in some cases to
be superior to contrast-enhanced CT (CECT) [37].
Moreover, CEUS is successful in providing hemodynamic information in areas where the slow
flow and insonation angle represent an impediment to Doppler mode.
The limitations of CEUS are:
a. the high costs of the systems able to operate in contrast mode (as compared to basic
ultrasound systems);
b. relatively steep and long learning curve;
c. specific artifacts;
d. the dependence on the patient’s habitus (especially for deep lesions).
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4.4. Experimental animal models
The development of the emerging CEUS applications often involves building a model that is
reproducible and based on easily controllable parameters. The animal models play an
important role in the development of new therapies, as well as in the validation of the imaging
techniques’ capability to evaluate the response to treatment. Implementing such a model is a
crucial step in the laborious process aimed for the final implementation of new diagnosis and
therapeutic strategies in clinical practice. Murine models are the most commonly used. This is
due to their relatively low cost, the possibility to obtain a wide range of transgenic animals
and the ease of CEUS application to this species. The CEUS examination of the rats follows the
same principles as in the case of human subjects. CA administration can be performed through
the lateral tail vein [38]. This approach may be sometimes inefficient due to the increased skin
rigidity and reduced vein caliber. Other authors have proposed alternative sites of adminis-
tration, such as intracardiac [39]. Real-time US monitoring of the catheter's progression allows
a precise placement of the needle tip and contributes to the success of the technique. This
administration route is not without drawbacks, since the rat’s accelerated heart rate can lead
to catheter displacement outside the heart. Contrast agents developed for humans can be used
effectively in animal models (e.g., SonoVue, Bracco Italy). There are also CAs specifically
developed for animal studies, such as Micromarker (Bracco, Geneva). They offer the possibility
to be combined with various components (e.g., Streptavidin), resulting in a molecular imaging
method that addresses specific structures expressed on the endothelium (e.g., VEGFR-2) [40].
One of the basic murine models, which can be easily obtained and has wide applicability, uses
the rat carcinosarcoma, known as the Walker 256 tumor. This can be grafted with high success
rates in both superficial and intracavitary sites (e.g., intraperitoneal). The application of CEUS
in these situations has implications for monitoring and quantifying the natural development
of tumor MC and for assessing the success of tumoricidal therapies (Figure 10) [39].
Figure 10. Appearance of an experimentally induced tumor by subcutaneous implantation in a Wistar animal model.
On the left the tumor (asterisk) is depicted in B-mode US. On the right the CEUS examination is displayed.
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4.5. Modern clinical applications
From 2004 onwards the European Federation of the Societies of Ultrasonography in Medicine
and Biology (EFSUMB) together with other entities such as The World Federation of Ultraso-
nography in Medicine and Biology (WFUMB) has made continuous efforts to publish guide-
lines and recommendations regarding the application of CEUS in hepatic and nonhepatic
pathologies [27, 32].
Its applications in rheumatology, in the form of contrast-enhanced Doppler ultrasonography
(Doppler CEUS) have been enhanced especially by the discovery of new treatments for active
rheumatoid arthritis that target the microvascularity [41]. Compared to the classic Doppler
technique, this application has significantly improved the detection of vascularity and the
therapeutic decision in inflammatory pathologies of the small and large joints [42, 43].
However, low MI CEUS is superior to Doppler CEUS in detecting intra-articular microvascu-
larity [44]. Also, the method provides valuable quantitative data through TIC, as revealed by
some studies that observed positive correlations between the peak signal intensity and
microvascular density (CD105+) in the case of psoriatic arthritis [45].
In the case of orchiepididymitis, the diagnosis is easily established by the clinical and DUS
examination of the patient. Additionally, CEUS may point out much earlier an abscess
formation, which appears as a nonenhancing structure, and consequently it improves the
therapeutic approach [46].
Figure 11. CEUS exploration of the intestinal wall in Crohn's disease, before (left image) and after treatment (right im-
age). The intestinal wall is outlined in green and before treatment it is strongly enhancing, as opposed to the posttreat-
ment findings where the enhancement pattern returned to a normal aspect. The adjacent fat (outlined in yellow)
presented similar patterns.
The applications in the pathology of the digestive tract and its glands are numerous and
diverse. One of these is the quantification of the intestinal wall vascularity in patients with
Crohn's disease [47, 48]. In this particular situation, where angiogenesis is the key element of
active disease, CEUS allows the assessment of the intestinal wall as well as of the adjacent fat,
the results being strongly correlated with those of the MR [49]. The CA enhancement pattern
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within the different bowel wall layers is correlated with the clinical parameters that charac-
terize the disease activity. The evaluation of CA behavior through TIC curves allows the
quantification of TTP, a parameter that is correlated with the values of the C reactive protein
(CRP), which is a surrogate inflammation marker – a short TTP reflects the increased values
of CRP encountered during the active stages of the disease [50]. Also, the elevation of TTP is
an indicator of the inflammatory changes resolution [50]. The development of strictures is one
of the possible complications of Crohn's disease in which CEUS can differentiate between the
inflammatory substrate (strong enhancement) and the fibrotic one (weak enhancement)
(Figure 11) [47, 51].
CEUS holds a distinct role in the appreciation of focal liver lesions since it is frequently
successful in establishing an accurate diagnosis or facilitates the decision of further investiga-
tions. Benign lesions present a specific and constant enhancement pattern during the arterial
and portal phases and no wash-out during the delayed phase [32]. Hemangiomas can be
accurately diagnosed in over 95% of the cases since they have a typical CEUS pattern – nodular,
peripheral enhancement during the arterial phase which progresses in a centripetal manner,
the uptake being partial or complete (Figure 12). During the portal venous phase there is
constant enhancement. A strong enhancement during the arterial phase is also found in focal
nodular hyperplasia (FNH), but the progression is centrifugal and during the delayed phase
the lesion may be hyper or isoenhancing compared to the adjacent parenchyma. During the
late phases the typical central scar may be identified as a hypoenhancing area (Figure 12)
[52].
Figure 12. CEUS of liver FNH and hemangioma. The FNH (arrows) presents hyperenhancement during the arterial (A,
B) and venous phases (C) that progresses centrifugally. The hemangioma (asterisk) shows intense peripheral enhance-
ment during the arterial phase (D) which progresses centripetally; the tumor is hyperenhanced in the late phase (E).
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In malignant liver tumors there is an early and abrupt uptake of the CA within the circulatory
bed followed by the CA wash-out from the region of interest in the end of the arterial phase
or the beginning of the venous phase. This phenomenon is explained by the existence of
arteriovenous communications. In over 97% of the cases HCC is hyperenhancing during the
arterial phase and becomes hypoenhancing during the late phase [32]. Highly differentiated
tumors may present delayed or absent wash-out, just like in the case of the well-differentiated
HCC which can be isoenhancing in these phases. Cholangiocarcinoma displays a different
behavior during the arterial phase, but during the subsequent phases a characteristic wash-
out is identified. CEUS has implications not only in the diagnosis, but also in the treatment of
tumors since it allows the guiding of local ablation techniques (ethanol injection or radio-
frequency ablation) by easily identifying the tumor and confirming the efficiency of coagula-
tion necrosis.
Renal tumors also benefit from this method. CEUS allows the differentiation between pseu-
dotumors and tumors and allows the diagnosis of benign and malignant cystic masses [53].
The sensitivity of the method in identifying enhancement at the level of the fine septa is
superior to that of CT, even though CT remains the standard method for the staging of
malignant cystic tumors. CEUS is also useful in the noninvasive diagnosis of bladder tumors
since it can differentiate between a blood clot and a mural tumor which is vascularized and
therefore enhances after CA administration.
Figure 13. CEUS aspect of testicular infarction. In the upper left image, a yellow ROI is placed inside the testicular
parenchyma and a blue ROI is placed upon the scrotal wall. The TICs for each ROI are plotted in the right half of the
image. The testicular parenchyma (yellow) shows no enhancement in contrast with the normally enhancing scrotal
wall (blue).
Regarding ischemic lesions, CEUS overcomes the limitations of DUS since it can differentiate
between a slow circulatory bed and an ischemic area. The accuracy of the method is similar to
that of contrast-enhanced CT and superior to DUS in the diagnosis of renal ischemia. Renal
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infarction appears as a triangular shaped area, with the base toward the renal capsule and
which does not enhance with CA, on the background of an enhancing renal parenchyma [54].
Infarction occurring in other organs provides similar CEUS findings (Figure 13).
5. Perspectives of the ultrasonographic evaluation of microcirculation
The discovery and use of new biological therapeutic agents not only for cancer treatment but
also for other conditions have created the need to evaluate the treatment response in a
noninvasive manner. In most cases, the effects of these therapies, especially in the early
treatment phases, elude the analysis capacity of the morphological imaging techniques.
Identifying the presence or absence of the therapeutic response in the initial phases of the
treatment influences decisively the therapeutic itinerary of the patient – functional imaging is
capable to assess these early changes. In the case of CEUS, the potential capability derives from
the quantitative analysis of TIC. The parameters obtained through TIC before and after the
initiation of a treatment with effects on microvascularity have the capacity to become surrogate
markers of the therapeutic answer. A series of clinical trials have focused on their analysis and
revealed relevant results [55]. For the low MI CEUS technique, the parameters that proved to
be useful are WIT; WOT; MTT and AUC [36, 55, 56]. The disadvantage of this method is the
lack of control on the CA concentration distributed at the level of the ROI, since it is manually
injected. High MI techniques (destruction replenishment) manage to overcome this limitation
by the automatic administration of the CA and by obtaining a stable plasmatic CA concentra-
tion. Other recent research directions have come to complete the ones already mentioned since
they demonstrated the potential of the TIC parameters to become surrogate markers of tumor
aggressiveness. The possibility to identify tumor aggressiveness in a noninvasive manner is
extremely important due to the potential impact on the efficient individualization of the
therapeutic strategy [56].
Recent technological discoveries allowed the development of 4D systems capable to follow the
CA kinetics in real-time. These present the advantage of an integrated assessment of the CA
kinetics within the whole tumoral mass or region of interest [57].
At the same time, the qualitative and quantitative data obtained through CEUS may be
subjected to automatic complex analyses, such as CART (Classification and Regression Trees)
that are based on artificial intelligence. They allow an integrated analysis of the CEUS
parameters together with those provided by DUS, B mode US, CT/MRI and the creation of a
complex, high accuracy, decision protocols [58].
The microbubbles used nowadays may be combined with various antibodies and therefore
the technique may target specific structures. The binding may be performed with multiple
antibodies at the same time. A recent study succeeded the triple marking of the CA against
αVβ-integrin, P-selectin and endothelial growth factor of the human breast cancer endothe-
lium and murinic angiosarcoma [59]. Binding the CA with biomarkers improves the visual-
ization of tumor angiogenesis and in the future these state-of-the-art methods will increase
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the sensitivity of CEUS in detecting and staging cancers and in evaluating the microcircula-
tion.
6. Conclusions
The ultrasonographic evaluation of vascularity is based on the Doppler technique and the
harmonic technique using CAs. CEUS is the recommended US method for the characterization
of microcirculation for which it provides a multivariate appreciation. The results of the
examination are displayed in real-time under the eyes of the examiner, while the quantitative
assessment of the CA kinetics parameters is easy to perform. These features allow a precise
definition of the healthy or pathologic state of an organ and the follow-up of treatment
response. The method is versatile and in the future it will open new perspectives for individ-
ualized, patient-centered therapy, with special benefits for oncologic patients.
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